ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
128 hedge funds and large institutions have $595M invested in Alder Biopharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 33 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
96% less call options, than puts
Call options by funds: $217K | Put options by funds: $5.13M
Holders
128
Holding in Top 10
2
Calls
$217K
Puts
$5.13M
Top Buyers
| 1 | +$37M | |
| 2 | +$6.88M | |
| 3 | +$6.78M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.5M |
| 5 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
+$6.27M |
Top Sellers
| 1 | -$21.2M | |
| 2 | -$14.8M | |
| 3 | -$8.82M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$8.27M |
| 5 |
PA
Perceptive Advisors
New York
|
-$7.99M |